Pathological changes of diabetic nephropathy are all except:
## **Core Concept**
Diabetic nephropathy, also known as diabetic kidney disease, is a serious complication of diabetes characterized by pathological changes in the kidneys. The primary alterations include glomerular damage, basement membrane thickening, and tubulointerstitial fibrosis. These changes are driven by hyperglycemia-induced activation of various pathways leading to inflammation, oxidative stress, and fibrosis.
## **Why the Correct Answer is Right**
The correct answer, ., represents a choice that does not align with the known pathological changes of diabetic nephropathy. Typically, diabetic nephropathy involves:
- **Glomerular basement membrane thickening**: An early change due to accumulation of extracellular matrix proteins.
- **Mesangial expansion**: Increased mesangial matrix and cells leading to reduced capillary lumen.
- **Kimmelstiel-Wilson nodules**: Characteristic nodular glomerulosclerosis.
- **Tubulointerstitial fibrosis**: A late change associated with disease progression.
## **Why Each Wrong Option is Incorrect**
- **Option A:** If A represents a known feature such as glomerular basement membrane thickening or mesangial expansion, it is incorrect because these are indeed pathological changes seen in diabetic nephropathy.
- **Option B:** Similarly, if B represents Kimmelstiel-Wilson nodules or tubulointerstitial fibrosis, it is incorrect for the same reason; these are established pathological changes.
- **Option C:** This option would be incorrect if it describes any of the hallmark changes like basement membrane thickening, mesangial expansion, or nodules.
## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **diabetic nephropathy is the leading cause of chronic kidney disease and end-stage renal disease worldwide**. Early detection through regular monitoring of urine albumin and serum creatinine can help in delaying progression through interventions like tight glycemic control, blood pressure management, and renin-angiotensin-aldosterone system (RAAS) blockade.
## **Correct Answer: D. **